EA201301082A1 - Способ изготовления инкапсулированных терапевтических продуктов и их применение - Google Patents

Способ изготовления инкапсулированных терапевтических продуктов и их применение

Info

Publication number
EA201301082A1
EA201301082A1 EA201301082A EA201301082A EA201301082A1 EA 201301082 A1 EA201301082 A1 EA 201301082A1 EA 201301082 A EA201301082 A EA 201301082A EA 201301082 A EA201301082 A EA 201301082A EA 201301082 A1 EA201301082 A1 EA 201301082A1
Authority
EA
Eurasian Patent Office
Prior art keywords
encapsulation
barrier
incapsulated
manufacturing
application
Prior art date
Application number
EA201301082A
Other languages
English (en)
Inventor
Мириам Леа Уилли Босманс
Люк Схоньянс
Гудмунн Скьяк-Браэк
Original Assignee
Бета-Селл Нв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бета-Селл Нв filed Critical Бета-Селл Нв
Publication of EA201301082A1 publication Critical patent/EA201301082A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)

Abstract

Изобретение относится к способам инкапсуляции, включающим микроинкапсуляцию на базе альгината для обеспечения иммунной защиты и долговременного функционирования биологического материала или терапевтических средств. Биологический материал или терапевтические средства окружают мембраной, сформированной превращением в гель полимера альгината. Более конкретно, но ни в коей мере не исключительно, система инкапсуляции предназначена для использования в области алло- и ксенотрансплантации. Мембрана представляет собой барьер, защищающий инкапсулированный материал, обеспечивающий долговечность и предотвращающий нежелательные воздействия с внешней стороны барьера, такие как воспалительные реакции или иммунные ответные реакции. Изобретение также ориентировано на способы изготовления и предоставления инкапсулированных продуктов для применения в клеточной терапии. Терапевтические продукты, полученные способом инкапсуляции, могут составлять метод облегчения или лечения ряда состояний.
EA201301082A 2011-03-29 2012-03-07 Способ изготовления инкапсулированных терапевтических продуктов и их применение EA201301082A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11160298 2011-03-29
PCT/EP2012/053868 WO2012130567A1 (en) 2011-03-29 2012-03-07 Method for encapsulated therapeutic products and uses thereof

Publications (1)

Publication Number Publication Date
EA201301082A1 true EA201301082A1 (ru) 2014-01-30

Family

ID=44455573

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301082A EA201301082A1 (ru) 2011-03-29 2012-03-07 Способ изготовления инкапсулированных терапевтических продуктов и их применение

Country Status (12)

Country Link
US (1) US20140017304A1 (ru)
EP (1) EP2691084A1 (ru)
JP (1) JP2014509617A (ru)
KR (1) KR20140051161A (ru)
CN (1) CN103619328A (ru)
AU (1) AU2012237375A1 (ru)
BR (1) BR112013024402A2 (ru)
CA (1) CA2831184A1 (ru)
EA (1) EA201301082A1 (ru)
MX (1) MX2013011040A (ru)
SG (1) SG193615A1 (ru)
WO (1) WO2012130567A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014326794B2 (en) 2013-09-24 2019-03-21 Giner, Inc. System for gas treatment of a cell implant
CN114344244A (zh) * 2015-03-23 2022-04-15 加利福尼亚大学董事会 薄膜细胞包囊装置
CN105274084A (zh) * 2015-10-15 2016-01-27 深圳爱生再生医学科技有限公司 脱乙酰几丁质/海藻酸钠干细胞微囊及其制备和培养方法
US20190125937A1 (en) * 2016-04-04 2019-05-02 Beta-O2 Technologies Ltd. Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof
ES2824752T3 (es) 2016-10-19 2021-05-13 Beta Cell Tech Pty Ltd Siembra de población celular en matrices dérmicas para el manejo de trastornos endocrinos
BR112019009712A2 (pt) 2016-11-15 2019-08-13 Giner Life Sciences Inc dispositivo de difusão gasosa percutânea adequado para uso com um implante subcutâneo
JP7121005B2 (ja) * 2016-11-23 2022-08-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 生物学的製剤の粒子媒介送達
BR112019020611A2 (pt) * 2017-04-06 2020-04-22 Seraxis Inc células terapêuticas macroencapsuladas e processos de uso das mesmas
JP7199632B2 (ja) 2017-05-04 2023-01-06 ガイナー，インク． 堅牢なインプラント可能なガス送達装置ならびにそれを含む方法、システムおよび装置
KR101952762B1 (ko) * 2017-05-08 2019-02-27 강원대학교산학협력단 알긴산과 콜라겐의 조합으로 생성된 줄기세포를 캡슐화하는 미세캡슐 조성물 및 그 제조방법
US20210128785A1 (en) * 2018-06-21 2021-05-06 Yale University Bioartificial vascular pancreas
US20210196646A1 (en) * 2018-08-15 2021-07-01 Wake Forest University Health Sciences Improved formulations for pancreatic islet encapsulation
CN109316464B (zh) * 2018-11-01 2020-12-11 长春万成生物电子工程有限公司 包含胰岛样细胞团的制剂
US11596913B2 (en) * 2021-07-16 2023-03-07 Clearh2O, Inc. Methods of high throughput hydrocolloid bead production and apparatuses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US5116747A (en) * 1989-08-11 1992-05-26 University Of Waterloo Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate
WO1991009119A1 (en) * 1989-12-13 1991-06-27 Trancel Corporation Improved alginate microcapsules, methods of making and using same
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
IL102785A (en) * 1991-08-20 1998-06-15 Univ Leicester Method for removing protein from a water- soluble gum and a method of making biocompatible capsules using said gum
US5762959A (en) * 1992-05-29 1998-06-09 Vivorx, Inc. Microencapsulation of cells
DE19904785A1 (de) * 1999-02-05 2000-08-10 Ulrich Zimmermann Verfahren zur Herstellung von stabilem Alginatmaterial
EP1146117B1 (en) 2000-04-12 2008-01-23 Beta-Cell N.V. A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
ITMI20032115A1 (it) * 2003-11-03 2005-05-04 Uni Degli Dustdi Di Pavia Allestimento di sistemi di coltura tridimensionale in
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
US20090214660A1 (en) * 2005-10-21 2009-08-27 Living Cell Products Pty Limited Encapsulation system
DE602006009631D1 (de) * 2006-05-10 2009-11-19 Biocompatibles Uk Ltd GLP-1 Peptide enthaltende kugelförmige Mikrokapseln, deren Produktion und deren Verwendung
IT1392356B1 (it) * 2008-12-19 2012-02-28 Università degli Studi di Perugia Procedimento di microincapsulamento di cellule del sertoli, microcapsule ottenute e loro impiego per la prevenzione e la cura del diabete mellito di tipo 1.

Also Published As

Publication number Publication date
CN103619328A (zh) 2014-03-05
CA2831184A1 (en) 2012-10-04
EP2691084A1 (en) 2014-02-05
US20140017304A1 (en) 2014-01-16
BR112013024402A2 (pt) 2016-12-13
AU2012237375A1 (en) 2013-10-10
MX2013011040A (es) 2014-08-22
WO2012130567A1 (en) 2012-10-04
SG193615A1 (en) 2013-11-29
KR20140051161A (ko) 2014-04-30
JP2014509617A (ja) 2014-04-21

Similar Documents

Publication Publication Date Title
EA201301082A1 (ru) Способ изготовления инкапсулированных терапевтических продуктов и их применение
EA201491299A1 (ru) Карбаматные соединения, их получение и применение
WO2015187596A3 (en) Antibody-drug conjugates, their preparation and their therapeutic use
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
EA201590870A1 (ru) АМИНОЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-a]ПИРИДИНКАРБОКСАМИДЫ И ИХ ПРИМЕНЕНИЕ
MX2012011994A (es) Tejido reticular que contiene insecticida.
NZ631034A (en) Targeting aminoacid lipids
WO2012024233A3 (en) Zwitterionic lipids
EA201391597A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
BR112013014242A2 (pt) composto da fórmula, composição farmacêutica, método de tratamento de doença de gaucher e método de aumento da quantidade de beta glicocerebrosidase nas células sanguíneas brancas
BR112015022597A2 (pt) partículas modificadoras da imunidade para o tratamento de inflamação
EA201401350A1 (ru) Бензимидазолы, модулирующие tnf-альфа
EA201171286A1 (ru) Новая технология изготовления индометацина
WO2011113019A3 (en) Ctla4 proteins and their uses
WO2016210384A3 (en) Bacteria engineered to treat metabolic diseases
EA201201661A1 (ru) Новые аминопиразолохиназолины
IN2014DN06092A (ru)
EA201300137A1 (ru) Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний, связанных с нейродегенеративными зоболеваниями
PH12015502535B1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
MX350120B (es) Cebo en gel para combatir insectos rastreros perjudiciales.
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
WO2010129339A3 (en) Compositions and methods for enhancing antigen-specific immune responses
BR112013007740A2 (pt) métodos para processamento de microesferas, microesferas processadas por tais métodos e seus usos
WO2012009603A3 (en) Transcranial magnetic stimulation for altering susceptibility of tissue to pharmaceuticals and radiation
BR112015010225A2 (pt) compostos tricíclicos e seus métodos de produção e utilização